LD-2 disclosure · 1st Quarter - Amendment
HORIZON PHARMA USA, INC
Client
- Description
- Biopharmaceutical development
- Location
- Illinois · United States of America
Registrant
- Description
- consultant lobbying
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesHealth Issues
Legislation to address opioids manufacturing and distribution Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA), vaccines and other various provisions.
LobbyistsCHARLES M BRAIN · mr A. J. WOJCIAK · HEATHER MCHUGH · BEAU` SCHUYLER
Covered position (CHARLES M BRAIN): Special Assistant to the President, Deputy Chief of Staff House Ways & Means Committee
Covered position (mr A. J. WOJCIAK): Senior Legislative Aide to Rep. Earl Pomeroy
Covered position (HEATHER MCHUGH): Legislative Director to Senator Charles Schumer
Covered position (BEAU` SCHUYLER): Legislative Director to Rep. John Tanner
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
H.R. 4710, 340B PAUSE Act, establishing a moratorium on the registration of new 340B hospitals and associated sites, and requiring reporting of program data. H.R. 1625, Consolidated Appropriations Act, 2018, provisions relating to manufacturers share of cost-sharing for Medicare beneficiaries in the donut hole phase of Part D plan coverage.
LobbyistsCHARLES M BRAIN · mr A. J. WOJCIAK · HEATHER MCHUGH · BEAU` SCHUYLER
Covered position (CHARLES M BRAIN): Special Assistant to the President, Deputy Chief of Staff House Ways & Means Committee